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Abstract 
Sortase (a transamidase) has been shown to be responsible for the covalent attachment 
of proteins to the bacterial cell wall. Anchoring is effected on secreted proteins 
containing a specific cell wall motif towards their C-terminus; that for sortase A (SrtA) in 
Gram positive bacteria often incorporates the sequence LPXTG. Such surface proteins 
are often characterised as virulence determinants and play important roles during the 
establishment and persistence of infection. Intra-mammary infection with Streptococcus 
uberis is a common cause of bovine mastitis, which impacts on animal health and 
welfare and the economics of milk production. Comparison of stringently produced cell 
wall fractions from S. uberis and an isogenic mutant strain lacking SrtA permitted 
identification of 9 proteins likely to be covalently anchored at the cell surface. Analysis of 
these sequences implied the presence of two anchoring motifs for S. uberis, the classical 
LPXTG motif and an additional LPXXXD motif.  
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Introduction 
 
Virulence determinants associated with the bacterial cell surface play an important role 
in the persistence and pathogenesis of bacterial infections through such processes as 
adherence to, and invasion of, host cells and subversion of the host response 1. The 
proteins involved are often candidates for inclusion in vaccines or targets for new 
therapeutic agents 2, 3.  
 
The surface of Gram-positive bacteria is decorated with many different macromolecules, 
including carbohydrates, teichoic acids, polysaccharides and proteins. In many species a 
subset of surface proteins have been reported to be covalently linked to the 
peptidoglycan matrix of the cell wall 1, 4, 5. In almost all studies to date, in Gram positive 
bacteria, several Archaea and Gram negative Proteobacteria, the mechanism of the 
covalent attachment of proteins relies on the transamidase, sortase 6. Sortase was first 
described in Staphylococcus aureus 7 and presently, five different classes of sortase 
enzyme have been identified in Gram positive bacteria 8, 9. Each class has been reported 
to anchor a specific and discrete subset of proteins by recognition of a distinct penta-
peptide motif within a suitable context within the substrate protein. 
 
The majority of covalently attached proteins are anchored by a single transpeptidase, 
sortase A (SrtA). Bacteria deficient in SrtA display an altered array of surface proteins 
and often altered virulence characteristics due to the lack of properties specifically 
associated with the sortase substrate proteins 5. Anchoring of proteins by SrtA is 
dependent on the substrate containing a signal peptide and a cell wall sorting motif. In 
many studies this has been shown to consist of a penta-peptide, typically, but not 
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exclusively, documented as LPXTG. This is typically followed by a C-terminal 
hydrophobic region and a short tail of charged amino acids at the C-terminus 10. In most 
cases, the sorting motif is located towards the C-terminus of the anchored protein, 
however in one case, an IgA protease from Streptococcus pneumoniae, a functional 
sorting motif was demonstrated towards the N-terminus of the protein 11.  
 
Characterization of the activity and specificity of SrtA has been based primarily on 
studies conducted on Staphylococcus aureus. In general, covalent attachment to the 
peptidoglycan follows secretion of the substrate protein via the Sec pathway and the 
concomitant cleavage of the N-terminal signal sequence (reviewed with particular 
reference to streptococcal and mycobacterial species in Rigel and Braunstein12). The 
secreted protein which is retained at the bacterial cell surface due to the hydrophobic 
domain and the positively charged C-terminus, is cleaved by SrtA between the threonine 
and glycine of the LPXTG motif 13, 14. SrtA subsequently effects the formation of a new 
amide bond between the resulting C-terminal threonine and the amine group of the 
penta-glycine peptides that form cross-bridges within the peptidoglycan 15. In 
streptococci the process is considered similar except that anchoring occurs between the 
substrate protein and the respective cross bridging peptide, penta-glycine being 
exclusive to Staphylococci. A recombinant version of SrtA from S. pyogenes was shown 
in vitro to catalyse the transpeptidation of LPXTG containing peptides to a di-alanine cell 
wall precursor mimic 16. 
 
Combining data from in silico genomic searches using algorithms such as PSORT with 
that from experimental detection of proteins in bacterial extracts 17, 18, has enabled 
identification of putative SrtA substrates. Alternatively, in silico analysis of genomic 
sequences utilising hidden Markov models 19 or the generation of alternative pattern 
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searching algorithms 4 have provided definitive lists of putative SrtA substrates that can 
be validated experimentally. However, sortase-anchored proteins that do not contain 
typical cell wall sorting motifs may not be identified using such approaches.  
 
Experimental identification of SrtA anchored proteins has proven difficult due to the 
presence of contaminating proteins. This has necessitated the production of extracts 
from highly purified cell wall fractions for analysis. A number of studies have used 2-DE 
and/or LCMS to identify sortase anchored proteins from bacterial cell wall fractions of 
staphylococcal and streptococcal species 20-26. These studies focused on analysis of 
fractions generated using cell wall hydrolysing enzymes such as mutanolysin or 
lysostaphin under osmotically protected conditions in an attempt to release proteins 
specifically from bacterial peptidoglycan. However, in almost all cases, the number of 
covalently anchored proteins identified was much lower than that predicted by 
bioinformatic analysis of the genome sequence. This may reflect the low abundance or 
lack of expression of these proteins in vitro, or may be due to inadequate separation and 
resolution of the target proteins; particularly during the isoelectric focusing of highly 
hydrophobic, highly basic, highly acidic or very large or small proteins attached to 
fragments of peptidoglycan 27, 28. Direct tryptic-digestion of purified cell wall fractions 29, 30 
or shaving of intact bacterial cells with trypsin 18, 31 and detection of the resulting peptides 
by LCMS/MS has been applied to identify increased numbers of surface associated 
proteins.  
 
Streptococcus uberis is one of the most common pathogens associated with bovine 
mastitis 32, 33 and impacts on animal health and welfare and the economics of milk 
production. The published genome of S. uberis (strain 0140J) contains a single coding 
sequence (CDS) with homology to SrtA 34 and seven CDSs containing an LPXTG motif 
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within a suitable context 34. Bioinformatic analysis of the genome also revealed a further 
two CDSs with a possible LPXAG sorting motif and a number of other CDSs that showed 
homology to proteins shown to be anchored in other Gram-positive bacteria but which 
lacked a recognised motif sequence 34.   
 
In this communication, we compared the proteomic analysis of tryptic peptides shaved 
from isolated cell walls of S. uberis and an isogenic, sortase-deficient mutant and 
discuss the output in the context of the identification/validation of SrtA anchored 
proteins, the sorting motif and the specificity of SrtA.  
 
Methods 
 
Bacterial strains and reagents: 
S. uberis strain 0140J (strain ATCC BAA-854 / 0140J), originally isolated from a clinical 
case of bovine mastitis in the UK, was used throughout this study. The SrtA mutant was 
isolated following PCR screening of a S. uberis 0140J pGh9::ISS1 mutant bank 35 
following a similar protocol to that described previously 36. The bacterium was routinely 
grown in Todd Hewitt (THB) or Brain Heart Infusion (BHI) broth (Oxoid Ltd, Cambridge 
UK) at 37oC. 
 
Isolation of cell wall proteins: 
Cell wall protein isolation was adapted from methods previously described 30, 37. Briefly, 
bacterial cultures were grown in either THB or BHI to either exponential or stationary 
phases of growth. Exponential cultures were grown in 1.5 litres of broth to an optical 
density of 0.6 at OD550nm whilst stationary phase cultures were grown in 1 litre of broth 
overnight. Bacteria were harvested by centrifugation (16,000 × g, 10 min, 4°C) and 
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washed consecutively with PBS, 0.1% (v/v) Nonidet P40 (NP40) (Sigma-Aldrich, St 
Louis, MO, USA) in PBS, and PBS. Bacteria were finally resuspended in PBS containing 
Complete protease inhibitors (Roche Diagnostics GmbH, Mannheim, Germany) and 
disrupted by bead beating in screw-capped microfuge tubes containing 0.1 mm 
zirconia/silica beads in 5 × 1 min intervals at maximum speed, with interspersed cooling 
periods on ice. Unbroken cells and beads were removed by two rounds of centrifugation 
(8,000 × g, 10 min, 4°C). The supernatants were then subjected to high speed 
centrifugation (125,000 × g, 30 min) and the resulting pellets resuspended in 4% 
SDS/PBS, heated at 80°C for 4 hours, then centrifuged (200,000 × g, 30 min). The 
resulting cell wall fragments were washed 4 times with MilliQ water at 30°C, harvested 
by centrifugation (as above). The washed cell wall fragments were resuspended in 50 
mM ammonium bicarbonate containing 1 μg of proteomics grade trypsin (Sigma) in a 
final volume of 200 µl and incubated with shaking overnight at 37°C. The samples were 
clarified by centrifugation (16,000 × g, 10 min) and the tryptic digestion stopped by the 
addition of formic acid (Sigma) to a final concentration of 0.1%; w/v.  
 
Preparation of S. uberis concentrated culture supernatant  
Complete protease inhibitors were added to cultures (400ml) of S. uberis 0140J and its 
isogenic SrtA mutant grown overnight in THB. Bacteria were removed from culture 
supernatant by centrifugation (16,000 × g, 10 min). The bacterial growth media was filter 
sterilised through a 0.22 μM filter (Millipore, Bedford, MA, USA) and concentrated 
approximately 100-fold using Amicon centrifugal filter devices (Millipore) with 10kDa 
molecular weight cut off. To precipitate proteins, 4 volumes of methanol and chloroform 
(3:1) was added to 1 volume of concentrated bacterial growth media. The preparation 
was vortexed and 2 volumes of MilliQ water were added prior to centrifugation (16,000 × 
g, 2 min). The upper phase was carefully removed and discarded. Proteins were 
7 
 
precipitated with 3 volumes of methanol, and collected by centrifugation (16,000 × g, 2 
min). The supernatant was discarded and the remaining pellet air-dried before 
resuspension in SDS-PAGE-loading buffer. 
 
Production and purification of recombinant sub0826, sub1154 and sub1370 
 
The predicted mature coding sequence of sub0826, sub1154 and sub1370 were 
amplified from genomic DNA by PCR using primer pairs 
p451 (5’-GATGAAAAAGTGATTAATGGTTCAGA-3’) and  
p452 (5’-TAGTTCCGATGTCGACCTTTTGTT-3’),   
p409 (5’-GAGCAATTGCAAAATGAAAAGC-3’) and  
p410 (5’-ATGTCAAAAGCCCGGTACCTTTACAG-3’)  
p480 (5’- GAAGAAGTGGTAACTGCTACAAAC-3’) and  
p481 (5’- TACTAACTTCTTGTCATCTTGGTACCTTTT), respectively. Each set of 
primers was designed to incorporate either a KpnI restriction site (sub1154 and 
sub1370) or a SalI restriction site (sub0826) to enable efficient directional cloning.  
 
Amplicons were generated for each construct (4.4 kb for Sub0826, 3.4 kb for Sub1154 
and 3.1 kb for Sub1370) using Phusion™ high fidelity polymerase (New England 
Biolabs, Ipswich, MA, USA), purified using a MinElute PCR Purification Kit (Qiagen 
GmbH, Hilden, Germany) and treated with KpnI or SalI (New England Biolabs) to 
facilitate directional cloning. Plasmid pQE1 (Qiagen) was digested with KpnI or SalI and 
treated with Antarctic phosphatase (all from New England Biolabs), to prevent self 
ligation. The amplicon and plasmid were ligated using T4 DNA Ligase (New England 
Biolabs) at 14oC according to the manufacturers’ instructions. Twenty microlitres of the 
ligation mixture was desalted 38 and approximately 10 ng of the desalted ligation mixture 
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was transformed into Escherichia coli M15 pREP4 (Qiagen). Recombinant clones were 
selected on LB Kan25µg/ml Amp50µg/ml agar plates.  
 
Overnight cultures containing each recombinant (6 x His-tagged) protein were sub-
cultured by dilution (1/30) into LB broth containing 50 µg/ml of ampicillin and 25 µg/ml of 
kanamycin and grown at 20C (sub1154 and sub0826) without shaking or 37oC 
(sub1370) with agitation (200rpm) for 2h. Protein expression was induced by addition of 
IPTG to a final concentration of 0.2 mM. Cultures were incubated for a further 2-4 hrs 
and bacterial cells harvested by centrifugation (8,000 × g; 20 min). Bacteria were lysed 
by the addition of CelLytic (Sigma) in the presence of protease inhibitors (Complete-
EDTA free; Roche) and recombinant proteins purified in the presence of the same 
inhibitors using HisSelect high flow cartridges (Sigma) according to the manufacturers’ 
instructions.  
 
Production of Sub0826, Sub1154 and Sub1370 antiserum in rabbits and immuno-
blotting  
Five aliquots of approximately 50μg freeze dried purified recombinant protein were 
supplied to Davids Biotechnologie (Regensburg, Germany) for serum production in 
rabbits. Anti-serum (50ml) was supplied filter sterilised and containing 0.02% sodium 
azide as a preservative.  
 
Detergent and media bacterial extracts were separated by sodium-dodecyl sulphate 
polyacrylamide (SDS-PAGE) on 10% gels and either transferred onto nitrocellulose 
membranes (Amersham Biosciences UK, Little Chalfont, UK) for immuno-detection or 
incubated in InstantBlue (Expedeon Protein solutions, Cambridge, UK) for detection of 
proteins. Transfer was performed at 170 mA for 1 hr in a (Biorad) Transblot apparatus in 
9 
 
transfer buffer consisting of 25mM Tris-base, 192mM glycine and 20% (v/v) methanol, 
pH 8.1-8.4. Membranes were incubated in a blocking solution of 1% skimmed milk 
powder in PBS at 4ºC overnight, washed three times for 5 min in PBS containing 0.1% 
Tween 20 (PBST) and then incubated for 1 hr in rabbit antisera diluted (1/5,000 anti-
sub0826; 1/10,000 anti-sub1154 or 1/15,000 anti-sub1370) in blocking solution. 
Membranes were washed three times for 5 min in PBST then incubated with goat anti-
rabbit immunoglobulin G conjugated to HRP (Southern Biotech, Birmingham, AL, USA) 
diluted 1/1000 in blocking buffer, for 1 hour. Membranes were washed (as above) and 
HRP conjugate detected using a solution of 4-chloronaphthol (0.5mg/ml) in PBS 
containing 16.7% methanol and 0.00015% (v/v) of H2O2 following incubation under dark 
conditions for 1 hour. Membranes were subsequently rinsed in PBS and allowed to dry.  
 
Peptide analysis by LC-MS 
LC MS/MS analysis was performed on a nanoAcquity UPLC system coupled to Q-Tof 
Premier Mass spectrometer (Waters Corporation). Tryptic peptides were desalted and 
concentrated on a C18 TRAP (180µm x 20mm, 5µm Symmetry, Waters), for 3 min at 
10µl/ min with 0.1% (v/v)  Formic acid, and resolved on a 1.7µm BEH 130 C18 column 
(100µm x 100mm, Waters)  attached to Waters UPLC Acquity HPLC. Peptides were 
eluted at 400 nl/ min with a linear gradient of 0-50% (v/v) acetonitrile/ 0.1% (v/v) formic 
acid over 30 min, followed by 85% (v/v) acetonitrile/ 0.1% (v/v) formic acid for 7 min.  
Eluted peptides were analysed on Q-Tof Mass Spectrometer in data directed acquisition 
mode, where a MS survey scan was used to automatically select multicharged peptides 
for further MS/MS fragmentation. From each survey scan up to three most intense 
peptides were selected for fragmentation. MS/MS collision energy was dependent on 
precursor ion mass and charge state. A reference spectrum was collected at every 30 
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seconds from the Glu-fibrinopeptide B (785.8426 m/z), introduced via a reference 
sprayer. 
 
The raw mass spectral data was processed with ProteinLynx Global Server 2.2.5 
(Waters Corporation, Milford, Massachusetts, USA) to generate peaklist files. The 
processing parameters with respect to noise reduction, de-isotoping, and centroiding 
were as follows: background subtract type: normal; background threshold: 20%; 
background polynomial: 5; smoothing type: Savitzky-Golay. Deisotoping and centroiding 
in MS mode: medium; threshold: 3%; centroid top: 80%. Deisotoping and centroiding in 
MS/MS mode: deisotoping type: medium; threshold: 1%. The mass accuracy of the 
spectra was further corrected by using the reference spectra from Glu-fibrinopeptide B.  
 
The resulting peaklist files were searched against a locally curated protein sequence 
database (1870 entries) of S. uberis 0140J (GenBank Accession AM946015) using 
Mascot ver. 2.2 (Matrix Science, London, UK). Precursor and fragment ion mass 
tolerance were set to +/- 200 ppm and +/- 0.2 Da respectively. Oxidation of methionine 
residue was allowed as a variable modification. Trypsin specificity was used for allowing 
for 1 missed cleavage.  The interpretation and presentation of MS/MS data was 
performed according to published guidelines 39. Decoy database searches were 
performed with a randomised sequence database of S. uberis 0140J and revealed a 
false discovery rate for peptide matches above an identity threshold of less than 4%. The 
score threshold for acceptance of a positive protein identification was ≥50 and with a 
requirement of a minimum of two unique peptide per protein hits.   
 
Results 
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Characterization of S. uberis SrtA mutant 
A SrtA mutant was isolated containing the 808bp, ISS1 element inserted between base 
pairs 248 and 249 of srtA in the reverse orientation. A translation product of the first 82 
residues of the 252 amino acids of SrtA was predicted which extended 18 residues into 
the ISS1 element before a stop codon was reached. Based on homology with known 
SrtA protein sequences, including those from the S. aureus and Streptococcus 
pyogenes, the predicted product did not contain the active site domain of SrtA (Fig. 1). 
Sequence analysis revealed that the catalytic site of S. uberis SrtA most likely lies 
between residues 84-252. The SrtA deficient mutant showed no differences in colony 
morphology or growth rates in Todd Hewitt (THB), brain heart infusion broth (BHI) or raw 
bovine milk in comparison with the wild-type strain (data not shown).  
 
Analysis of wild type and SrtA deficient Streptococcus uberis cell wall proteomes 
under different growth conditions 
 
To determine which proteins were likely to be attached to the cell wall by SrtA, 
stringently washed cell wall preparations were generated from the wild type and SrtA 
mutant strains. Cell wall derived peptides were obtained from both exponential (OD550nm 
= 0.6) and stationary (OD550nm > 1) phases of growth and from two different growth 
media (THB and BHI) and subjected to reverse-phase LCMS/MS for identification. 
Each protein from wild-type S. uberis identified as per the defined criteria (Materials and 
methods) was subjected to further analysis (Supplementary Tables 1 and 2) and 
compared with a similar data set generated from cell wall peptides of the SrtA mutant 
under the same growth conditions.  
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Cell wall fractions from wild type S. uberis grown in either THB or BHI media yielded a 
total of 17 and 13 protein identities, respectively (Supplementary Tables 1 and 2). The 
total number of unique proteins identified from the growth conditions was relatively 
limited (20 proteins), which can probably be attributed to the stringent conditions used in 
the production of the cell wall fractions.  
 
The amino acid sequence of each identified protein was analysed for typical 
characteristics of SrtA anchored substrates. Of the proteins detected in the wild type 
strain, nine showed typical characteristics of SrtA anchored proteins; i.e. an LPXTG-like 
motif, the presence of a signal peptide and regions of C-terminal hydrophobicity (Table 
1). The presence of these proteins within the corresponding sample from the SrtA 
mutant (Supplementary Tables 1 and 2) was also determined. Of the putative SrtA 
anchored substrates only one, sub0145, was detected in any of the samples generated 
from the SrtA mutant strain, grown in BHI media. In this case, the SrtA mutant samples 
yielded 5 peptides compared to 26 unique peptide matches from the equivalent wild type 
fractions (Supplementary Table 2). 
 
Two putative SrtA substrate proteins were identified exclusively in extracts from THB-
grown stationary phase cultures; a predicted subtilase-like serine protease (sub0826) 
and collagen-like protein (sub1095). Both proteins showed sequence similarities to other 
proteins known to be anchored in streptococci. In each case, three and two peptides 
respectively were identified for these proteins (representing coverage of 1.9 and 4.1 %, 
respectively of the total sequence). The low prevalence of peptides from each of these 
proteins may suggest their low abundance under the growth conditions tested, however, 
neither was identified in any SrtA mutant derived sample.  
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Four of the putative SrtA substrates (sub0135, sub0826, sub1154 and sub1370) did not 
possess the typical LPXTG penta-peptide anchoring motif. However, in each case a 
hexa-peptide (LPXXXD/E) showing similarity to sorting motifs from other CDSs of 
streptococci was evident (Table 2). One protein, sub1370 identified as a zinc 
carboxypeptidase, displayed all the typical characteristics of an anchored protein, but 
possessed an anchoring motif of LPALAD. This protein was detected in samples 
generated under every growth condition tested and was only present in wild-type 
fractions and never observed in the SrtA mutant fractions. Furthermore, multiple 
peptides from this protein were detected (covering between 18 and 27 % of the total 
coding sequence possibly indicating a high prevalence of this protein. The remaining five 
putative sortase substrates (sub0207, sub0241, sub0145, sub0888, sub1730) 
possessed ‘classical’ LPXTG or LPXAG motifs; in four of these cases the amino acid 
found in position 6 was acidic (D or E).  
 
Detection of the proteins sub0826, sub1154 and sub1370 in concentrated culture 
supernatants of wild type and the SrtA deficient mutant  
Rabbit antisera directed against sub0826, sub1154 or sub1370 were used to detect the 
presence of these proteins in concentrated culture supernatants of S. uberis 0140J and 
the SrtA mutant. The proteins corresponding to sub0826, sub1154 and sub1370 were 
detected in far greater abundance in the growth media obtained from the SrtA mutant 
(Fig. 2), however in each case a trace of the full length protein was detected in culture 
supernatant from the wild type strain. 
 
Discussion 
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In this study, we demonstrate the utility of a method of stringent cell wall isolation 
coupled with LCMS/MS to analyse strains of S. uberis with and without sortase A (SrtA). 
This enabled identification of nine proteins that were specifically associated with wild 
type cell walls; any or all of which may contribute to the interactions between S. uberis 
and its surrounding environment.  
 
Unlike many other streptococci, S. uberis 0140J has a single sortase (sub0881; srtA) 
within its genome 34. Analysis of this revealed an N-terminal region of hydrophobic amino 
acids containing both a membrane anchoring motif and a signal peptide in addition to the 
conserved sortase signature (TLXTC) containing the essential catalytic cysteine residue 
40. These features are indicative of a secreted protein that is retained at the cytoplasmic 
membrane. Protein sequence comparison by BLASTP showed the sequence had the 
highest sequence identity with SrtA from two other pyogenic streptococci; Streptococcus 
equi subspecies zooepidemicus (79%) and S. pyogenes (71%) (Fig.1). In contrast, the 
sequence similarity to SrtA from S. aureus is approximately 31%.  
 
To identify proteins that were likely to be anchored by SrtA, we focused on the analysis 
of proteins which were strongly associated with the bacterial peptidoglycan of the wild 
type strain. The harsh purification process that was used to enrich cell wall fractions via 
differential centrifugation and prolonged heating in the presence of SDS has been 
previously demonstrated to significantly increase the numbers of identified, covalently-
anchored proteins 29, 30. In our study, we identified 9 proteins likely to be anchored by 
sortase within a total of 20 identified proteins. Initially, peptides isolated from cell wall 
fractions from exponentially growing and stationary phase cultures from each growth 
medium were analysed by LCMS/MS separately in order to maximise the potential for 
protein identification induced from the different growth conditions. However, no proteins 
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were identified exclusively during early phases of growth. Due to the limited number of 
spectra obtained for analysis, which can probably be attributed to the stringent 
conditions used to obtain the purified cell walls, the peaklists generated for each strain 
grown in either THB or BHI medium at different stages of growth were combined. A 
decoy-database search allowed estimation of a false discovery rate of less than 4% of 
the peptides above identity scores. By limiting positive identities to those with MASCOT 
Mowse scores higher than 50 and only analysing protein identities with more than two 
unique peptide hits, the confidence in positive identification for these proteins was 
significantly higher. Furthermore, by analysing each protein identity for typical 
characteristics of SrtA anchored proteins and cross referencing for the absence of these 
proteins in cell wall fractions from the SrtA mutant, we could confirm the presence of 
nine SrtA anchored proteins. 
 
Most of the identified proteins were present on cell walls from bacteria grown in both 
THB and BHI media, with two exceptions; the subtilase-like serine protease, sub0826 
and the collagen-like protein, sub1095. These were only detected on cell walls from 
bacteria grown in THB. It is possible these proteins are specifically regulated; induced in 
THB or repressed in BHI.  
 
The list of SrtA-anchored proteins detected and identified during this investigation 
correlated well with that predicted during bioinformatic annotation of the completed 
genome sequence 34. The prediction identified nine CDSs with characteristics consistent 
with SrtA anchored substrates and a further four CDSs that showed strong homology to 
proteins known to be anchored in other streptococci. The latter group, however, did not 
contain typical (LPXXG) anchor motifs and were considered to be possible rather than 
probable SrtA anchored sequences. Of the thirteen CDSs identified three (sub0164, 
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sub0764 and sub1739) were considered pseudogenes and one (sub0348) was 
considered to be a gene fragment. Eight of the nine remaining predicted SrtA anchored 
substrates were identified in the present investigation. The failure to detect one putative 
cell wall anchored protein identified from the genome as sub0241 may be due to the low 
abundance of this protein in the fractions analysed, or possibly due to lack of expression 
under the in vitro growth conditions used. Not unsurprisingly no peptides corresponding 
to the pseudogenes or the gene fragment were detected.   
 
This investigation therefore confirmed the likely cell wall anchoring of those CDSs with 
atypical sorting motifs identified during genome annotation (sub0135, sub0826 and 
sub1154). Additionally, the present study identified a further protein likely to be anchored 
by SrtA (sub1370) that was not identified by bioinformatics. 
 
In the absence of the SrtA enzyme, proteins normally anchored at the surface are likely 
to be released directly into the bacterial growth media. Indeed, the selective release of 
three such proteins (all putatively identified as proteases) containing non-typical 
anchoring motifs (sub0826, sub1154 and sub1370) was confirmed by immunoblotting of 
concentrated culture supernatants; providing further evidence that despite the absence 
of an LPXTG/LPXXG motif these proteins were anchored to the bacterial cell by SrtA. 
  
Of the nine proteins identified as SrtA anchored in this study, a number show similarity to 
known streptococcal virulence determinants or known cell wall anchored proteins. The 
putative fructan beta-fructosidase FruA (sub0135), shares 55% similarity at the protein 
level with a fructan hydrolase of Streptococcus mutans, an enzyme required for the 
transport or metabolism of sucrose 41. Localisation of this enzyme has found it to be 
either secreted 42 or anchored to the cell wall 43 depending upon growth conditions. It is 
17 
 
thought that the enzyme is anchored to the cell wall and released in response to an 
environmental stimulus, much like the anchored protein WapA of S. mutans 44. The 
product of the CDS sub1154 shows similarity to the C5a peptidase of S. pyogenes (34% 
similar at the protein level), another cell wall anchored virulence determinant of 
streptococci 45. This enzyme is also released from the cell wall with the resulting 
fragment capable of inhibiting the recruitment of phagocytes to the site of infection 46.  
 
The lactoferrin binding protein (Lbp, sub0145) has been identified as a possible 
virulence determinant of S. uberis and has been demonstrated as able to bind bovine 
lactoferrin 47. The concentration of this iron-chelating compound increases in the 
mammary gland during infection 48 as part of the innate response to infection. Whilst iron 
limitation is known to have an anti-microbial effect on some mastitic pathogens, including 
E. coli and S. aureus, it appears to have little effect on S. uberis 49, 50.  
 
Analysis of the anchoring motifs of each of the covalently anchored proteins revealed the 
presence of the classical LPXTG motif (or LPXAG) in five of the anchored proteins 
(sub0145, sub0207, sub0888, sub1095 and sub1730) and the presence of an alternate 
anchoring motif of LPXXXD in the remaining anchored proteins (sub0135, sub0826, 
sub1154 and sub1370). Early reports of putative anchoring motifs by Fischetti et al 51 
reported highly conserved hexa-peptide sequences at the C-terminal end of 11 known 
surface proteins of Gram positive cocci with a consensus sequence of LPXTGE. Upon 
identification of the SrtA enzyme in S. aureus 7 it became apparent that the conserved 
anchoring motif sequence for many Gram positive bacteria was LPXTG. Confirmation 
that this motif was favoured for enzymatic cleavage was tested by substituting individual 
amino acids into the a penta-peptide LPTEG library and measuring for kinetically 
favoured substrates 52.  
18 
 
 
Within Gram positive bacteria, the majority of proteins anchored by SrtA appear to 
conform to the LPXTG motif, however a number of variations of the anchoring 
sequences have been reported 1, 52 with most reporting variation by single amino acid 
residues in the latter half of the sortase cleavage site. However, SrtA from Clostridium 
difficile recognises motifs containing SPXTG or PPXTG 9, whilst that from Lactobacillus 
plantarum recognises LPQTXE as a motif 19, 53. 
 
In streptococcal species most anchored proteins conform to the traditional LPXTG motif; 
however, there are a number of exceptions. Apart from the four proteins with alternate 
anchoring motifs in S. uberis identified in this study, a number are also found in 
S. agalactiae, S. equi, S. pyogenes and one in S. pnemoniae (Table 2). One common 
feature to most of these proteins is an LPXTXD/E motif which suggests another 
kinetically favoured anchoring motif exists when the 5th residue has been modified from 
the traditional glycine. It appears that the conformation of the protein at this region, or 
indeed the proximity of acidic residues at position 6 of this motif may be equally 
important for cell wall anchoring by the SrtA enzyme in the absence of the LPXTG motif. 
The implication of this finding is that some SrtA anchored proteins of other bacterial 
species may have been disregarded, particularly during comparisons conducted 
exclusively in silico. For example, analysis of the S. uberis genome for proteins with an 
N-terminal signal peptide, a carboxy terminal LPXXG motif, a C-terminal hydrophobic 
region and a tail of charged amino acid residues identifies 9 potential SrtA substrates 
containing LPXTG with a further two possessing LPXAG motifs. Each of these proteins 
is recognised as an anchored protein by the cellular localization program PSORT 54. 
Additionally, the proteins sub0135, sub0826 and sub1154 are identified by PSORT as 
cell wall anchored, based on solely on similarity with other known SrtA anchored 
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proteins. The S. uberis carboxypeptidase sub1370 is not identified, however, using 
PSORT and is not identified using other programs designed to identify cell wall attached 
proteins 4, 19. It was only the direct experimental comparison of cell wall peptides from 
wild-type and the SrtA isogenic mutant in this study that identified this protein as 
covalently anchored. Further analysis of the S. uberis genome searching for other 
LPXXXD/E motifs and proteins with typical sortase anchoring characteristics did not 
reveal any further potentially SrtA-anchored proteins. 
 
In conclusion, the ability to obtain highly purified peptidoglycan enriched fractions of the 
S. uberis cell walls and comparison of the protein repertoires present in the wild-type and 
SrtA deficient strains has allowed the identification of nine SrtA cell wall anchored 
proteins of S. uberis. The identification and analysis of the anchoring motifs of these 
proteins identifies two anchoring motifs, the traditional LPXTG and the alternate 
LPXXXD motifs and highlights the potential for the presence of alternate cell wall 
anchoring motifs, either LPXTXD/E or LPXXXD for this and a number of other 
streptococcal species.  
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S.aureus        MKKWTNR-----------LMTIAGVVLILVAAYLFAKPHIDNYLHDKDKDEKIEQYDKNV  
S.uberis        MAESRRRKKGKSTFSDKLRSFLAVILLIVGLLLLFNKPIRNTLIAWNSNRYQVQHVTKDT  
S.equi          --------------MSFARGILVVLLLIIGLALLFNKPIRNTLIAWNSNKYQVTKVSKKT  
S.pyogenes      MVKKQKRRKIKS--MSWARKLLIAVLLILGLALLFNKPIRNTLIARNSNKYQVTKVSKKQ  
S.mutans        MKKERQSRKKRS----FLRTFLPILLLVIGLALIFNTPIRNALIAWNTNRYQVSNVSKKD  
S.agal          MRNKKKSHGFFN----FVRWLLVVLLIIVGLALVFNKPIRNAFIAHQSNHYQISRVSKKT  
                            SP/TM Region 
 
S.aureus        KEQASKDK-------------KQQAKPQIPKDKSKVAGYIEIPDADIKEPVYPGPATPEQ  
S.uberis        IQKNKEADSSFDFSAVQAVSTDTVLKAQMEAQKLPVIGGIAIPDVGINLPIFKGLGNTEL  
S.equi          IKKNKEAKSSFDFQAVQPVSTESILQAQMDAQQLPVIGGIAIPELGINLPIFKGLGNTEL  
S.pyogenes      IKKNKEAKSTFDFQAVEPVSTESVLQAQMAAQQLPVIGGIAIPELGINLPIFKGLGNTEL  
S.mutans        IEHNKAAHSSFDFKKVESISTQSVLAAQMAAQKLPVIGGIAIPDLKINLPIFKGLDNVGL  
S.agal          IEKNKKSKTSYDFSSVKSISTESILSAQTKSHNLPVIGGIAIPDVEINLPIFKGLGNTEL  
 
S.aureus        LNRGVSFAEENESLDDQNISIAGHTFIDRP---NYQFTNLKAAKKGSMVYFKVGNETRKY  
S.uberis        IYGAGTMKENQVMGGDNNYSLASHHIFGMAGSSQMLFSPLERAKVGMAIYVTDKEKIYHY  
S.equi          IYGAGTMKEDQVMGGENNYSLASHHIFGLTGSSEMLFSPLERAKEGMSIYLTDKERIYEY  
S.pyogenes      IYGAGTMKEEQVMGGENNYSLASHHIFGITGSSQMLFSPLERAQNGMSIYLTDKEKIYEY  
S.mutans        TYGAGTMKNDQVMG-ENNYALASHHVFGMTGSSQMLFSPLERAKEGMEIYLTDKNKVYTY  
S.agal          SYGAGTMKENQIMGGPNNYALASHHVFGLTGSSKMLFSPLEHAKKGMKVYLTDKSKVYTY  
 
 
S.aureus        KMTSIRDVKPTDVGVLDEQKGKDKQLTLITCDDYNEKTGVWEKRKIFVATEVK-------  
S.uberis        DINSVQTVTPDRIDVINDTPGF-KEITLVTCTDAEATERIIVKGLLKEEMNFNDAPKKVL  
S.equi          EINAVFTVTPERIDVINDTPGL-KEVTLVTCTDYEATERIIVKGAIKNEYEFNKAPDDVL  
S.pyogenes      IIKDVFTVAPERVDVIDDTAGL-KEVTLVTCTDIEATERIIVKGELKTEYDFDKAPADVL  
S.mutans        VISEVKTVTPEHVEVIDNRPGQ-NEVTLVTCTDAGATARTIVHGTYKGENDFNKTSKKIK  
S.agal          TITEISKVTPEHVEVIDDTPGK-SQLTLVTCTDPEATERIIVHAELEKTGEFSTADESIL  
 
S.aureus        ------------- 206 
S.uberis        NAFNHSYNQVAIE 252 
S.equi          KAFNHSYNQMST- 237 
S.pyogenes      KAFNHSYNQVST- 249 
S.mutans        KAFRQSYNQISF- 246 
S.agal          KAFSKKYNQINL- 247 
 
Figure 1: Sortase A sequence alignment  
 
Sequence alignment of the sortase enzymes from Streptococcus uberis (S. uberis; Accession 
number YP_002562210) with Staphylococcus aureus (S. aureus; Accession number 
YP_001333460) as well as the most closely related bacterial species according to BLASTP 
comparisons including Streptococcus equi subspecies zooepidemicus (S. equi; Accession 
number YP_002744471), Streptococcus pyogenes (S. pyogenes; Accession number 
NP_269304), Streptococcus mutans (S. mutans; Accession number NP_721500), and 
Streptococcus agalactiae (S. agalactiae; Accession number YP_329677) performed using 
ClustalW. Conserved amino acids proposed to be important in the active site of the enzyme are 
highlighted in red and the equivalent catalytic domains are highlighted in grey. The number of 
amino acid residues is indicated at the end of each sequence and the putative signal peptide and 
transmembrane region at the N-terminal region of the proteins is marked (SP/TM region). The 
amino acids highlighted in red are conserved in sortase enzymes from Gram-positive bacteria, 
including the conserved signature motif of the enzyme (TLXTC) which contains the catalytic 
cysteine residue that is essential for the cleavage of the scissile threonine-glycine bond in 
substrate proteins 40. 
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Figure 2: Identification of Sub0826, Sub1154 and Sub1370 from extracts of Streptococcus 
uberis 0140J.  
 
Immunoblots of protein extracts from S. uberis 0140J and the srtA mutant probed with rabbit 
antisera generated against Sub0826 (A), Sub1154 (B) and Sub1370 (C). Precipitated media 
extracts from 0140J (lane 1) and srtA mutant (lane 2) were analysed respectively, with molecular 
weight standards indicated. 
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     Combined THB growth phases  Combined BHI growth phases 
Genea 
 
Protein annotation Putative 
sortase 
anchor 
Molecular 
mass 
(Da)b 
MASCOT  
score  
No. of 
peptides 
matchedc 
Total  
spectral  
counts 
Coverage 
(%)d 
MASCOT  
score 
No. of 
peptides 
matchedc 
Total  
spectral  
counts 
Coverage 
(%)d 
sub0135 FruA: Putative 
fructan beta-
fructosidase 
precursor  
LPMTSDS 142,956 570 10 11 12.5 1323 18 26 23.4 
sub0145 Lbp: Putative 
lactoferrin binding 
protein 
LPSTGDK 57,829 1851 23 51 37.4 3909 26 93 48.9
 e 
sub0207 Putative surface 
anchored protein 
LPMAGER 53,765 139 3 4 7.8 261 5 6 13.6 
sub0826 Putative surface 
anchored subtilase 
family protein 
LPETRDS 168,468 50 3 3 1.9 - - - - 
sub0888 Putative surface 
anchored protein 
LPPTGSQ 29,230 256 2 4 18.0 313 2 4 18.0 
sub1095 SclB: Putative 
collagen like surface 
anchored protein 
LPSTGDK 47,642 131 2 3 4.1  - - - 
sub1154 ScpA: Putative C5a 
peptidase precursor 
LPKTVDS 127,957 165 6 7 6.0 414 11 13 14.4 
sub1370 Putative zinc-
carboxypeptidase 
LPALADG 116,563 3268 17 55 26.7 1220 18 25 22.3 
sub1730 Putative surface 
anchored protein 
LPSTGED 40,439 387 4 9 13.8 232 4 5 13.8 
 
Table 1: Sortase anchored proteins identified in cell wall extracts of S. uberis 0140J cultured in THB or BHI media  
a Gene and protein annotation according to the genomic sequence of Streptococcus uberis 0140J 34 
b Theoretical molecular mass values for protein precursors obtained from Artemis database from the Wellcome Trust Sanger Institute 
(http://www.sanger.ac.uk/) 
c  Number of unique peptide hits for each protein  
d Percentage of protein sequence covered by experimentally detected peptides 
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e 5 peptides identified in the SrtA mutant cell wall fraction. With this exception, none of the other proteins were detected in cell wall samples from 
the SrtA mutant  
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Bacterial 
species 
Gene a Protein annotation   Atypical 
sorting 
motif 
Protein 
reference a 
Reference 
S.uberis  FruA; 
sub0135 
Putative fructan beta-fructosidase 
precursor 
LPMTSDS CAR40555 This study  
S. uberis  Lbp; 
sub0145 
Putative surface anchored 
subtilase family protein 
LPETRDS CAR41854 This study 
S. uberis  ScpA; 
sub1154 
Putative C5a peptidase precursor  LPKTVDS CAR42550 This study 
S. uberis  sub1370 Putative zinc-carboxypeptidase LPALADG CAR42963 This study 
S. agalactiae  SAG0416 Streptococcal C5a peptidase  LPSTSDR AAM99322 55 
S. agalactiae SAG1333 5'-nucleotidase family protein LPKTNSE AAN00204 55 
S. equi 
subspecies 
zooepidemicus 
SZO_10150 Putative cell surface-anchored 
C5A peptidase precursor 
LPKTSEK CAW99349 56 
S. equi 
subspecies 
equi 
FneC; 
SEQ_1606 
Putative collagen-binding 
collagen-like cell surface-
anchored protein  
LPKTNDT CAW94597 56 
S. equi 
subspecies 
equi 
FneE; 
SEQ_0555 
Putative collagen and fibronectin-
binding cell surface-anchored 
protein  
LPRTNEA CAW92812 56 
S. equi 
subspecies 
equi 
SEQ_0256 Putative cell surface-anchored 
protein 
LPATADT CAW92309 56 
S. pneumoniae spr1771 Subtilisin-like serine protease LPNTSEN AAL00574 57 
S. pyogenes ScpA; 
M6_Spy1718 
C5a peptidase  LPTTNDK AAT87853 58 
S. pyogenes Grab; 
spyM18_1369 
Protein G-related alpha 2M-
binding protein (GRAB) 
LPTTSEE AAL97965 59 
 
Table 2: Atypical sortase anchoring motifs in Streptococcal species 
a Gene and protein annotation reference according to the NCBI protein database  
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Gene a Protein annotation Molecular 
mass  
(Da) b  
MASCOT 
Score  
Unique 
peptides 
matched 
Total  
spectral 
counts 
Coverage 
(%) c 
Putative 
 C-terminal 
anchor 
Signal 
peptide 
 
Presence in 
SrtA mutant 
fraction  
sub1370 Putative zinc carboxypeptidase  116,563 3268 17 55 26.7 LPALADG Present No 
sub0145 Lactoferrin binding protein  57,829 1851 23 51 37.4 LPSTGDK Present No 
sub0135 Putative fructan beta-fructosidase 
precursor  
142,956 570 10 11 12.5 LPMTSDS Present No 
sub1730 Putative surface anchored protein  40,439 387 4 9 13.8 LPSTGED Present No 
sub1717 Putative glycine-betaine-binding 
permease protein  
63,184 276 5 6 11.2 None Absent Yes 
sub0888 Putative surface anchored protein 29,230 256 2 4 18.0 LPPTGSQ Present No 
sub1326 C4-dicarboxylate anaerobic carrier 
protein  
53,657 237 3 6 7.2 None Present Yes 
sub0750 Putative fructose-specific 
phosphotransferase system (PTS), 
IIABC component  
66,892 234 3 5 6.2 None Absent Yes 
sub1154 Putative C5a peptidase precursor  127,958 165 6 7 6.0 LPKTVDS Present No 
sub1328 Arginine deiminase  46,336 151 3 3 7.8 None Absent Yes 
sub0799 Putative lactose-specific 
phosphotransferase system (PTS), IIBC 
component 2 
60,633 142 2 3 4.1 None Absent  Yes 
sub0207 Putative surface anchored protein 53,765 139 3 4 7.8 LPMAGER Present No 
sub1095 Collagen like surface anchored protein  47,642 131 2 3 4.1 LPSTGDK Present No 
sub1357 Putative  membrane protein 45,516 109 2 3 7.7 None Present Yes 
sub0063 Aldehyde-alcohol dehydrogenase 2 96,479 93 2 2 4.0 LPLVKDM Absent Yes 
sub0533 Sugar phosphotransferase system (PTS), 
IIC component 
47,152 84 2 4 4.3 None Absent Yes 
sub0826 Putative surface anchored subtilase 
family protein  
168,468 50 3 3 1.8 LPETRDS Present No 
 
Supplementary Table 1: Summary of all identified proteins in cell wall extracts of S. uberis 0140J cultured in THB media  
 
a Gene and protein annotation according to the genomic sequence of Streptococcus uberis 0140J 34 
b Theoretical molecular mass values for protein precursors obtained from Artemis database from the Wellcome Trust Sanger Institute 
(http://www.sanger.ac.uk/) 
c Percentage of protein sequence covered by experimentally detected peptides 
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Gene a Protein annotation Molecular 
mass  
(Da) b  
MASCOT 
Score  
Unique 
peptides 
matched 
Total 
spectral 
counts 
Coverage 
(%) c 
Putative  
C-terminal 
anchor 
Signal 
peptide 
 
Presence in 
SrtA mutant 
fraction 
sub0145 Lactoferrin binding protein  57,829 3909 26 93 48.9 LPSTGDK Present Yes d 
sub0135 Putative fructan beta-fructosidase 
precursor  
142,956 1323 18 26 23.4 LPMTSDS Present No 
sub1370 Putative zinc carboxypeptidase  116,563 1220 18 25 22.3 LPALADG Present No 
sub1154 Putative C5a peptidase precursor  127,958 414 11 13 14.4 LPKTVDS Present No 
sub0888 Putative surface anchored protein 29,230 313 2 4 18.0 LPPTGSQ Present No 
sub0207 Putative surface anchored protein 53,765 261 5 6 13.6 LPMAGER Present No 
sub1730 Putative surface anchored protein  40,439 232 4 5 13.8 LPSTGED Present No 
sub0655 Enolase 47,308 225 4 4 12.6 None Absent Yes 
sub0750 Putative fructose-specific 
phosphotransferase system (PTS), IIABC 
component  
66,892 209 4 4 7.7 None Absent Yes 
sub1717 Putative glycine-betaine-binding permease 
protein  
63,184 148 3 3 7.0 None Absent Yes 
sub1328 Arginine deiminase  46,336 91 2 2 5.6 None Absent Yes 
sub0604 Elongation factor Tu 43,914 74 2 2 7.3 LPAGTEM Absent Yes 
sub1543 Putative sucrose specific 
phosphotransferase system (PTS) IIABC 
component 
66,128 60 2 2 3.2 None Absent No 
 
Supplementary Table 2: Summary of all identified proteins in cell wall extracts of S. uberis 0140J cultured in BHI media 
 
a Gene and protein annotation according to the genomic sequence of Streptococcus uberis 0140J 34 
b Theoretical molecular mass values for protein precursors obtained from Artemis database from the Wellcome Trust Sanger Institute 
(http://www.sanger.ac.uk/) 
c Percentage of protein sequence covered by experimentally detected peptides 
d 5 peptides identified in the SrtA mutant cell wall fraction  
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Sortase (SrtA) is responsible for covalently anchoring a subset of proteins to cell walls of 
Gram positive bacteria, often through a C-terminal motif of LPXTG. In the absence of 
SrtA, these proteins are either released or retained only loosely on the bacterial surface. 
Such anchored proteins are frequently characterised as virulence determinants and 
considered prime targets for therapeutics and vaccine development. Intra-mammary 
infection with Streptococcus uberis is one of the most common causes of mastitis in UK 
with major economic and animal welfare implications. Comparison of trypsinised 
stringent cell wall extracts of S. uberis and a srtA mutant by LCMS/MS allowed the 
identification of nine proteins likely to be anchored by SrtA. Two anchoring motifs are 
present in this protein subset, the traditional LPXTG and the alternate LPXXXD/E, which 
highlights the potential for the presence of alternate cell wall anchoring motifs for this 
and a number of other streptococcal species. 
 
